255 related articles for article (PubMed ID: 19450641)
1. Skin-specific promoters for genetic immunisation by DNA electroporation.
Vandermeulen G; Richiardi H; Escriou V; Ni J; Fournier P; Schirrmacher V; Scherman D; Préat V
Vaccine; 2009 Jul; 27(32):4272-7. PubMed ID: 19450641
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of intradermal DNA electrotransfer for immunisation.
Vandermeulen G; Staes E; Vanderhaeghen ML; Bureau MF; Scherman D; Préat V
J Control Release; 2007 Dec; 124(1-2):81-7. PubMed ID: 17854939
[TBL] [Abstract][Full Text] [Related]
3. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
[TBL] [Abstract][Full Text] [Related]
4. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.
Ross R; Sudowe S; Beisner J; Ross XL; Ludwig-Portugall I; Steitz J; Tüting T; Knop J; Reske-Kunz AB
Gene Ther; 2003 Jun; 10(12):1035-40. PubMed ID: 12776161
[TBL] [Abstract][Full Text] [Related]
6. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
7. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses.
Grønevik E; Mathiesen I; Lømo T
J Gene Med; 2005 Sep; 7(9):1246-54. PubMed ID: 15822067
[TBL] [Abstract][Full Text] [Related]
8. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB
Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
[TBL] [Abstract][Full Text] [Related]
10. Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
Ni J; Nolte B; Arnold A; Fournier P; Schirrmacher V
Vaccine; 2009 Sep; 27(40):5480-7. PubMed ID: 19616491
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV.
Jounai N; Okuda K; Kojima Y; Toda Y; Hamajima K; Ohba K; Klinman D; Xin KQ
J Gene Med; 2003 Jul; 5(7):609-17. PubMed ID: 12825200
[TBL] [Abstract][Full Text] [Related]
12. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
13. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
14. Improvement of DNA vaccine immunogenicity by a dual antigen expression system.
Sasaki S; Takeshita F; Oikawa T; Kojima Y; Xin KQ; Okuda K; Ishii N
Biochem Biophys Res Commun; 2004 Feb; 315(1):38-43. PubMed ID: 15013422
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix).
Babiuk S; Baca-Estrada ME; Pontarollo R; Foldvari M
J Pharm Pharmacol; 2002 Dec; 54(12):1609-14. PubMed ID: 12542889
[TBL] [Abstract][Full Text] [Related]
16. Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
Pringle IA; McLachlan G; Collie DD; Sumner-Jones SG; Lawton AE; Tennant P; Baker A; Gordon C; Blundell R; Varathalingam A; Davies LA; Schmid RA; Cheng SH; Porteous DJ; Gill DR; Hyde SC
J Gene Med; 2007 May; 9(5):369-80. PubMed ID: 17410613
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation.
Yen HH; Scheerlinck JP
Vaccine; 2007 Mar; 25(14):2575-82. PubMed ID: 17224210
[TBL] [Abstract][Full Text] [Related]
19. An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
Lai MD; Chen CS; Yang CR; Yuan SY; Tsai JJ; Tu CF; Wang CC; Yen MC; Lin CC
Cancer Gene Ther; 2010 Mar; 17(3):203-11. PubMed ID: 19851354
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.
Dobaño C; Widera G; Rabussay D; Doolan DL
Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
